Key facts
- It has raised $20K; the latest was Angel (individual) ($20K) in Sep 2025.
- Flxion Medical has filed 1 Form D with the SEC, most recently Sep 2025 ($21K sold to 1 investors).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Flxion Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Flxion Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Flxion Medical
Developer of a medical device intended for the delivery of emergency medications. The company specializes in the development and provision of safety auto-injectors, including epinephrine and Naloxone pens, and it offers an affordable emergency device capable of delivering medications via intranasal, intramuscular, and intravenous routes, offering versatility in critical situations, enabling healthcare professionals and individuals to administer life-saving treatments in a timely and effective manner.
- Sector
- Healthcare
- Founded
- 2025
- Website
- flxionmedical.com/
- Ownership
- Privately Held (backing)
Flxion Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Flxion Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Flxion Medical in its N-PORT filings yet. We sweep new filings monthly.